On air · 1 of 3 networks
Cellecta, Inc.
- cellecta.com
- Healthcare & Life Sciences
- US
- 28 employees
Cellecta, Inc.’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 35. Watch Cellecta, Inc. with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 30 Oct 2026 | See all 35 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 18 Oct 2026 | Collect them with the API → |
| Running | 100+ | Ads on the Google Ads Transparency Center | Checked 24 Oct 2026 | Collect them with the API → |
Cellecta, Inc. has no live LinkedIn ads. Its Facebook page had no active ads on 18 Oct 2026, and we recorded 100+ Google ads on 24 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 2 Oct 2026
Identifying antigen-specific TCRs among millions of T-cell clones can feel like searching for a needle in a haystack. Join Dr. Katharina Lindner, Postdoctoral Researcher at the German Cancer Research Center (DKFZ), to explore a high-throughput approach combining antigen-specific T-cell expansion with TCR deep sequencing to identify reactive TCRs and track immune responses over time.
- LINKEDIN · IMAGESince 2 Oct 2026
Want to learn more about the rapidly evolving techniques of immune repertoire profiling? Discover the newest assays for profiling T and B cell receptors in our latest presentation and learn more about how adaptive immunity is being applied to areas like organ transplantation, cancer, autoimmune diseases and more.
- LINKEDIN · IMAGESince 2 Oct 2026
Want to learn more about the cutting-edge techniques being used in immune repertoire profiling and phenotyping of T and B cells? Explore the latest advancements in adaptive immunity in this presentation as Alex Chenchik discusses how they will revolutionize discoveries applicable to novel diagnostics and therapeutics.
- LINKEDIN · IMAGESince 27 May 2026
What if cancer dependencies have been hiding in plain sight? This webinar reveals how long non-coding RNAs which were once dismissed as non-functional, are essential to cancer cell survival. See how the IsoScan platform pinpoints the specific isoforms behind tumor growth and what that means for the future of RNA-targeted therapy.
- LINKEDIN · IMAGESince 27 May 2026
Long non-coding RNAs have long been overlooked but new research is changing that. In this webinar, discover how the IsoScan platform enables isoform-level resolution to uncover hundreds of essential lncRNAs that drive tumor growth and progression, with direct implications for precision oncology.
- LINKEDIN · IMAGESince 5 Nov 2025
Looking to better understand immune repertoires and advance your work in immunotherapy or vaccine development? Join Dr. Alex Chenchik of Cellecta and Dr. April Mueller of Albert Einstein College of Medicine for an in-depth discussion on innovative methods for expanding antigen-specific T cells and mapping their clonal architecture through adaptive immune receptor (AIR) profiling.
6 of 35 adsSign up to see every Cellecta, Inc. ad, filter by format and date, and get alerts on new ones.
See all 35 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.